3:30pm Chair Introduction

Gregory Fiore, Chief Executive Office, Exacis Therapeutics

3:35pm Presentation: Racial and Ethnic Diversity in Immuno-Oncology Clinical Trials

• Review the current landscape of patient diversity in immuno-oncology trials leading to FDA approval
• Discuss challenges and opportunities to increase patient diversity in oncology trials

Samik Upadhaya, Assistant Director of Scientific Affairs, Cancer Research Institute

3:50pm Presentation: Focusing on Donor Characteristics and Efficient Selection to Improve Allogeneic Cell Therapy Outcomes

• How proven transplant infrastructure deliver cell and gene therapies
• The complexity of HLA in cell selection
• The use of machine learning in informing cell/source selection

Martin Maiers, Vice President, Research, Be The Match BioTherapies

4:05pm Presentation: TBA

Kevin Ramdas, Director, Medical Affairs and Clinical Operations, Longeveron

4:20pm Presentation: Clinical Trial Ecosystem in Cell Therapy and The Need for Patient Centric Trial Design and Execution

Tunç Toker, Chief Operating Officer, Galen Therapeutics

4:35pm Closing Panel with Q&A

With all session participants